RecruitingNot ApplicableNCT06769607

Evaluation of a Novel Auto-Adjusting Positive Airway Pressure Algorithm for the Treatment of Obstructive Sleep Apnea Clinical Study


Sponsor

ResMed

Enrollment

80 participants

Start Date

Apr 10, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to assess the effectiveness of an investigational algorithm in the treatment of obstructive sleep apnea.


Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • Participants willing to give written informed consent.
  • Participants who can read and comprehend English.
  • Participants who ≥ 18 years of age
  • Participants who have been using a ResMed AirSense 10 or 11 device.
  • Participants currently using AutoSet (APAP) mode.
  • Participants being established on PAP therapy for the treatment of OSA for approximately >3 months.
  • Participants who can participate in the study for up to 8 weeks.

Exclusion Criteria6

  • Participants using Bilevel flow generators.
  • Participants using CPAP, AutoSet for Her
  • Participants who are or may be pregnant.
  • Participants with a preexisting lung disease/ condition that would predispose them to pneumothorax (for example: COPD, lung cancer; fibrosis of the lungs; recent (< 2years) case of pneumonia or lung infection; lung injury.
  • Participants believed to be unsuitable for inclusion by the researcher.
  • Participants who are currently enrolled in other medical clinical studies

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEInvestigational algorithm

Investigational algorithm developed for the treatment of Obstructive Sleep Apnea.

DEVICEControl algorithm

Released algorithm intended for the treament of Obstructive Sleep Apnea


Locations(1)

ResMed Ltd

Bella Vista, New South Wales, Australia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06769607


Related Trials